ADDvantage Technologies Announces Financial Results for the Fiscal First Quarter of 2017
Feb 14, 2017 13:04 pm UTC| Business
BROKEN ARROW, Okla., Feb. 14, 2017 -- ADDvantage Technologies Group, Inc. (NASDAQ:AEY), today announced its financial results for the three month period ended December 31, 2016, which includes the financial results for...
ADDvantage Technologies Announces Financial Results for the Fiscal First Quarter of 2017
Feb 14, 2017 13:04 pm UTC| Business
BROKEN ARROW, Okla., Feb. 14, 2017 -- ADDvantage Technologies Group, Inc. (NASDAQ:AEY), today announced its financial results for the three month period ended December 31, 2016, which includes the financial results for...
Heat Biologics to Present at the Genitourinary Cancers Symposium
Feb 14, 2017 13:04 pm UTC| Business
DURHAM, N.C., Feb. 14, 2017 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to activate a patient’s immune system against cancer, announced that it will present a...
ADDvantage Technologies Announces Financial Results for the Fiscal First Quarter of 2017
Feb 14, 2017 13:04 pm UTC| Business
BROKEN ARROW, Okla., Feb. 14, 2017 -- ADDvantage Technologies Group, Inc. (NASDAQ:AEY), today announced its financial results for the three month period ended December 31, 2016, which includes the financial results for...
Heat Biologics to Present at the Genitourinary Cancers Symposium
Feb 14, 2017 13:04 pm UTC| Business
DURHAM, N.C., Feb. 14, 2017 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to activate a patient’s immune system against cancer, announced that it will present a...
Heat Biologics to Present at the Genitourinary Cancers Symposium
Feb 14, 2017 13:03 pm UTC| Business
DURHAM, N.C., Feb. 14, 2017 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to activate a patient’s immune system against cancer, announced that it will present a...
Heat Biologics to Present at the Genitourinary Cancers Symposium
Feb 14, 2017 13:04 pm UTC| Business
DURHAM, N.C., Feb. 14, 2017 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to activate a patient’s immune system against cancer, announced that it will present a...